Pathway Mutation Accumulate Perturbation Score: A prognostic and predictive biomarker for immunotherapy in advanced gastric cancer

20260 citationsJournal Articlegold Open Access

Authors

Yuming Xing · Beijing University of Posts and Telecommunications

Abstract

The PMAPscore-based risk model is a robust tool for predicting survival and immunotherapy responses in patients with advanced GC, supporting its clinical application for treatment stratification.

Topics & Keywords

Cancer Immunotherapy and Biomarkers Gastric Cancer Management and Outcomes Immunotherapy and Immune Responses

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Advances in Clinical and Experimental Medicine

Volume 35, Issue 4, pp. 0-0

DOI: 10.17219/acem/206937

Field-Weighted Citation Impact: 0.00